Literature DB >> 6287744

Epstein-Barr virus in cerebrospinal fluid during infectious mononucleosis encephalitis.

J A Schiff, J A Schaefer, J E Robinson.   

Abstract

Epstein-Barr virus (EBV) was recovered from cerebrospinal cells (but not from cell-free fluid) of a patient with meningoencephalitis complicating infectious mononucleosis. This finding suggests that virus-altered B lymphocytes can invade the central nervous system and may play a direct role in the pathogenesis of neurologic sequelae of EBV infections. Several mechanisms by which these cells can cause neurologic manifestations are discussed.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6287744      PMCID： PMC2596000     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN： 0044-0086


  15 in total

1.  Primary Epstein-Barr-virus infections in acute neurologic diseases.

Authors:  C Grose; W Henle; G Henle; P M Feorino
Journal:  N Engl J Med       Date:  1975-02-20       Impact factor: 91.245

2.  Epstein-Barr virus antibodies in the cerebrospinal fluid. A case of infectious mononucleosis with encephalitis.

Authors:  J H Joncas; L Chicoine; F Thivierge; M Bertrand
Journal:  Am J Dis Child       Date:  1974-02

3.  Observations on the type of infection by Epstein-Barr virus in peripheral lymphoid cells of patients with infectious mononucleosis.

Authors:  A B Rickinson; J E Jarvis; D H Crawford; M A Epstein
Journal:  Int J Cancer       Date:  1974-12-15       Impact factor: 7.396

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Infectious mononucleosis presenting as acute cerebellar syndrome.

Authors:  R G Lascelles; M Longson; P J Johnson; A Chiang
Journal:  Lancet       Date:  1973-09-29       Impact factor: 79.321

7.  Relationships between abnormal IgG index, oligoclonal bands, acute phase reactants and some clinical data in multiple sclerosis.

Authors:  O Christensen; J Clausen; T Fog
Journal:  J Neurol       Date:  1978-08-25       Impact factor: 4.849

8.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

9.  Host-determined differences in expression of surface marker characteristics on human and simian lymphoblastoid cell lines transformed by Epstein-Barr virus.

Authors:  J E Robinson; W A Andiman; E Henderson; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Infectious mononucleosis at the Yale-New Haven Medical Center, 1946-1955.

Authors:  J C NIEDERMAN
Journal:  Yale J Biol Med       Date:  1956-06
View more
  4 in total

1.  Acute cerebellar syndrome complicating infectious mononucleosis.

Authors:  G J Hankey; M Sadka; R S Goodheart; D M Hoffman
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

2.  Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man.

Authors:  Daniela Francisci; Alessandra Sensini; Daniela Fratini; Maria Vittoria Moretti; Maria Laura Luchetta; Antonino Di Caro; Giuliano Stagni; Franco Baldelli
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

Review 3.  DNA immunization and central nervous system viral infection.

Authors:  J L Whitton; R S Fujinami
Journal:  Adv Virus Res       Date:  2001       Impact factor: 9.937

4.  Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.

Authors:  Barbara Serafini; Barbara Rosicarelli; Diego Franciotta; Roberta Magliozzi; Richard Reynolds; Paola Cinque; Laura Andreoni; Pankaj Trivedi; Marco Salvetti; Alberto Faggioni; Francesca Aloisi
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.